Personal information

No personal information available

Activities

Collapse all

Employment (1)

Children's Hospital of Richmond at Virginia Commonwealth University: Richmond, VA, US

2013-02-01 to present | Professor (Pediatrics)
Employment
Source: Self-asserted source
Michael S. Schechter

Works (15)

Impact of UPLIFT, a group telehealth intervention, on symptoms of depression and anxiety in adults with CF

Journal of Cystic Fibrosis
2025-03 | Journal article
DOI: 10.1016/j.jcf.2024.11.008
Contributors: Michael S. Schechter; Andrea Molzhon; Robin S. Everhart; Le Kang; Rachel Weiskittle; Brittany Castleberry; Nancy J. Thompson
Source: check_circle
Crossref

Race, genetic ancestry, and socioeconomic status – a tangled web

Journal of Cystic Fibrosis
2025-03 | Journal article
DOI: 10.1016/j.jcf.2025.03.005
Contributors: Michael S. Schechter
Source: check_circle
Crossref

Factors associated with prescription of elexacaftor/tezacaftor/ivacaftor among people with cystic fibrosis aged 12 years or older with at least one F508del allele

Journal of Cystic Fibrosis
2025-01 | Journal article
DOI: 10.1016/j.jcf.2024.10.006
Contributors: Georgene E Hergenroeder; Jonathan V Todd; Josh S. Ostrenga; Christopher H Goss; Raksha Jain; Wayne Morgan; Gregory S. Sawicki; Michael S Schechter; Elizabeth A Cromwell; Clement L Ren
Source: check_circle
Crossref

Treatment of small as well as large declines in lung function enhances recovery to baseline in people with CF

Pediatric Pulmonology
2024-12 | Journal article
DOI: 10.1002/ppul.27176
Contributors: Michael S. Schechter; Joshua S. Ostrenga; Elizabeth A. Cromwell; Clement L. Ren; Aliza K. Fink; D. B. Sanders; Wayne J. Morgan
Source: check_circle
Crossref

Impact of Treating Small and Large Declines in Lung Function in Cystic Fibrosis

2024-06-07 | Preprint
DOI: 10.22541/au.171779960.03067662/v1
Contributors: Michael Schechter; Joshua S. Ostrenga; Elizabeth A. Cromwell; Clement Ren; Aliza K. Fink; Don Sanders; Wayne J. Morgan
Source: check_circle
Crossref

The impact of switching to race-neutral reference equations on FEV1 percent predicted among people with cystic fibrosis,

Journal of Cystic Fibrosis
2024-05 | Journal article
DOI: 10.1016/j.jcf.2024.03.013
Contributors: Margaret Rosenfeld; Elizabeth A. Cromwell; Michael S. Schechter; Clement Ren; Patrick A. Flume; Rhonda D. Szczesniak; Wayne J. Morgan; Raksha Jain
Source: check_circle
Crossref

Impact of Elexacaftor/Tezacaftor/Ivacaftor on Healthcare Resource Utilization and Associated Costs Among People With Cystic Fibrosis in the US: A Retrospective Claims Analysis

Pulmonary Therapy
2023-12 | Journal article
DOI: 10.1007/s41030-023-00241-z
Contributors: Michael S. Schechter; Natalia Sabater-Anaya; Gerry Oster; Derek Weycker; Hongsheng Wu; Emilio Arteaga-Solis; Sukirti Bagal; Lisa J. McGarry; Kate Van Brunt; Jessica Morlando Geiger
Source: check_circle
Crossref

Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study

Journal of Cystic Fibrosis
2023-07 | Journal article
DOI: 10.1016/j.jcf.2023.04.008
Contributors: S.M. Rowe; J.B. Zuckerman; D. Dorgan; J. Lascano; K. McCoy; M. Jain; M.S. Schechter; S. Lommatzsch; V. Indihar; N. Lechtzin et al.
Source: check_circle
Crossref

Obesity in Cystic fibrosis: prevalence, trends and associated factors data from the US cystic fibrosis foundation patient registry

Journal of Cystic Fibrosis
2022-09 | Journal article
DOI: 10.1016/j.jcf.2022.03.010
Contributors: Sylvia Szentpetery; Gabriela S. Fernandez; Michael S. Schechter; Raksha Jain; Patrick A. Flume; Aliza K Fink
Source: check_circle
Crossref

Adaptations to the RVA Breathes clinical trial due to the COVID-19 pandemic

Contemporary Clinical Trials Communications
2021-12 | Journal article
DOI: 10.1016/j.conctc.2021.100871
Contributors: Robin S. Everhart; Katherine W. Dempster; Devon Withers; Suzanne E. Mazzeo; Rosalie Corona; Leroy R. Thacker, II; Michael S. Schechter
Source: check_circle
Crossref

Speaking of pandemics...

Journal of Cystic Fibrosis
2021-07 | Journal article
DOI: 10.1016/j.jcf.2021.04.017
Contributors: Michael S. Schechter
Source: check_circle
Crossref

Decreased survival in cystic fibrosis patients with a positive screen for depression

Journal of Cystic Fibrosis
2021-01 | Journal article
DOI: 10.1016/j.jcf.2020.07.020
Contributors: Michael S. Schechter; Joshua S. Ostrenga; Aliza K. Fink; David H. Barker; Gregory S. Sawicki; Alexandra L. Quittner
Source: check_circle
Crossref

Evaluating Long-Term Benefits of Chronic Azithromycin. Furthering Our Quest for Precision Medicine

American Journal of Respiratory and Critical Care Medicine
2020-02-15 | Journal article
DOI: 10.1164/rccm.201911-2234ED
Contributors: Lisa Saiman; Michael S. Schechter
Source: check_circle
Crossref

Origins of growth deficiencies in cystic fibrosis

Thorax
2019-05 | Journal article
DOI: 10.1136/thoraxjnl-2019-213076
Contributors: Trang N Le; Michael S Schechter
Source: check_circle
Crossref

Reevaluating approaches to cystic fibrosis pulmonary exacerbations

Pediatric Pulmonology
2018-11 | Journal article
DOI: 10.1002/ppul.24125
Contributors: Michael S. Schechter
Source: check_circle
Crossref

Peer review (5 reviews for 1 publication/grant)

Review activity for Journal of cystic fibrosis. (5)
How many people are using ORCID?